Current & Novel Immuno-Oncology Drug Evaluation Methods via Humanized Mouse Models

Time: 9:30 am
day: Conference Day Two

Details:

  • Introduction and history of immuno-oncology drug development and the importance of using humanized mouse models to address scientific questions
  • Evaluation of current IO platforms and new methods from LIDE, including analysis of several case studies
  • Understanding the spatiotemporal interaction between tissue-infiltrating immune cells and cancer cells via imaging mass cytometr

Speakers: